Founding Team
Nicole Baker, PhD
​
CEO
Immunologist and Pharmacovigilance professional with extensive knowledge on medical affairs, regulatory affairs, pharmacovigilance and clinical trials, gained by leading and managing global, multi-disciplinary teams. Overall 20 years’ experience gained in academia, pharma and regulators.
Bruno Ohana, PhD
​
CTO
Technologist and Engineering Leader with broad industry experience spanning a career of over 20 years, having performed senior engineering/engineering management roles across various industries from Cloud Infrastructure, Fintech, and AI in Healthcare.
Academic and Industry Partners
Get in Touch
Contact us to learn more about how we use artificial intelligence to deliver faster, accurate and high quality literature screening for drug safety.